IP Library Granted Patent US 12,213,954
Granted Patent B2
US 12,213,954 · App. 18/681,394 · Granted Feb 4, 2025

Colchicine solution

Inventors: Ioannis Psarrakis (Lavrion, GR); Konstantinos Lioumis (Lavrion, GR)
Assignee: PHARMA-DATA RESEARCH AND DEVELOPMENT SINGLE MEMBER S.A.
A61K31/165A61K9/08A61K47/10A61K47/12A61K47/14A61K47/36A61K47/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,213,954
App. No.
18/681,394
Granted
Feb 4, 2025
Kind
B2
Abstract

Described is a stable buffered aqueous colchicine solution or suspension being free of benzyl alcohol, comprising colchicine, a water miscible solvent and a preservative, characterized in that the solution comprises 0.01-1.0 w/v % colchicine, 2.5-15.0 w/v % glycerol and 0.05-1 w/v % preservative, the pH of the solution or suspension being 4.5-7.0. A method for the preparation thereof is also disclosed.

Claims (21)

1. A buffered aqueous colchicine solution or suspension being free of benzyl alcohol, propylene glycol and thickener, comprising colchicine, a water miscible solvent and a preservative, wherein the solution or suspension comprises 0.02-1.0 w/v % colchicine, 2.5-15.0 w/v % glycerol and 0.05-1 w/v % preservative, the pH of the solution or suspension being 3.5-7.0.

2. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 0.022-0.035 w/v % colchicine.

3. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 5-12 w/v % glycerol.

4. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 0.10-0.40 w/v % preservative.

5. Buffered aqueous colchicine solution or suspension of claim 1 , wherein the preservative is chosen from the group, consisting of methyl paraben, ethyl paraben, propyl paraben, butyl paraben, sorbic acid, potassium sorbate, and combinations thereof.

6. Buffered aqueous colchicine solution or suspension of claim 1 , having a pH of 4.5-6.5.

7. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 0.05-2.0 w/v % buffering agent.

8. Buffered aqueous colchicine solution or suspension of claim 1 , comprising a buffering agent chosen from the group consisting of hydrochloric acid, acetic acid, ammonia solutions, monoethanolamine, diethanolamine, triethanolamine, meglumine, sodium citrate, citric acid, lactic acid, phosphoric acid, propionic acid, sulphuric acid, tartaric acid, potassium bicarbonate, potassium citrate, potassium hydroxide, sodium bicarbonate, sodium borate, and sodium hydroxide.

9. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 1.0 w/v % or less antioxidant.

10. Buffered aqueous colchicine solution or suspension of claim 9 , wherein the antioxidant is chosen from the group, consisting of butylated hydroxyl anisole, butylated hydroxyl toluene, tocopherol, ascorbyl palmitate, ascorbic acid, sodium metabisulfite, sodium sulphite, sodium thiosulfate, propyl gallate, and combinations thereof.

11. Buffered aqueous colchicine solution or suspension of claim 1 , being free of antioxidant.

12. Buffered aqueous colchicine solution or suspension of claim 1 , comprising a sweetening agent, wherein the amount of sweetening agent in the solution or suspension has a sweetening power that corresponds with the sweetening power of 20-500 w/v % saccharose.

13. Buffered aqueous colchicine solution or suspension of claim 12 , wherein the sweetening agent is an artificial sweetening agent, chosen from the group consisting of sucralose, sodium saccharin, aspartame, alitame, acesulfame-K, cyclamate, stevioside, glycyrrhizin, neohesperidin, dihydrochalcone, thaumatin, and combinations thereof.

14. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 0.05-0.3 w/v % sweetener.

15. Buffered aqueous colchicine solution or suspension of claim 1 , comprising, in addition to glycerol, a water-miscible organic solvent selected from the group consisting of polyols, alcohols, acetone, phthalates, dimethyl sulfoxide, dimethylacetamide, glycofurol, isopropyl myristate, isopropyl palmitate, propylene carbonate, pyrrolidine, glycerine triacetate, triethyl citrate, triolein, and a combination of two or more thereof.

16. Buffered aqueous colchicine solution or suspension of claim 15 , wherein the ratio of the water-miscible organic solvent with glycerol is 1-5:10 glycerol.

17. Buffered aqueous colchicine solution or suspension of claim 1 , comprising 0.05-0.2 w/v % flavouring agent.

18. Buffered aqueous colchicine solution or suspension of claim 17 , wherein the flavouring agent is selected from the group consisting of forest fruits flavour, grapefruit, orange, lime, lemon, mandarin, pineapple, strawberry, raspberry, mango, passion fruit, kiwi, apple, pear, peach, apricot, cherry, grapes, banana, cranberry, blueberry, black currant, red currant, gooseberry, lingonberries, cumin, thyme, basil, chamomile, valerian, fennel, parsley, camomile, tarragon, lavender, dill, bergamot, salvia , aloe vera balsam, spearmint, peppermint, eucalyptus, and combinations of two or more thereof.

19. Buffered aqueous colchicine solution or suspension of claim 1 , wherein the solution or suspension comprises at least 95% colchicine after 24 months storage at 25° C. at a relative humidity of 60% as compared to the amount of colchicine at the beginning of the storage.

20. Buffered aqueous colchicine solution or suspension of claim 1 , wherein the solution or suspension comprises less than 3% total impurities after 24 months storage at 25° C. at a relative humidity of 60%.

21. Buffered aqueous colchicine solution or suspension of claim 15 , wherein the water miscible organic solvent is selected from the group consisting of alkane triols, alkane diols, polyethylene glycol, ethanol, isopropyl alcohol, acetone, dibutyl phthalate, diethyl phthalate, dimethyl phthalate, dimethyl sulfoxide, dimethylacetamide, glycofurol, isopropyl myristate, isopropyl palmitate, propylene carbonate, pyrrolidine, glycerine triacetate, triethyl citrate, triolein, and a combination of two or more thereof.

Assignments (2)
CHANGE OF NAME Recorded Nov 19, 2024
From: PHARMA-DATA S.A.
To: PHARMA-DATA RESEARCH AND DEVELOPMENT SINGLE MEMBER S.A.
Reel/Frame 069406/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2024
From: PSARRAKIS, IOANNIS; LIOUMIS, KONSTANTINOS
To: PHARMA-DATA S.A.
Reel/Frame 066390/0614 →
Priority Claims (1)
NL 2028937 · Aug 6, 2021 · national
Continuity (2)
Provisional Application 63262070 · Oct 4, 2021
Related Publication 20240277638A1 · Aug 22, 2024
References Cited (3)
US 9907751B2 · Muni et al. · 2018 [cited by applicant]
CN 110448527A · 2019 [cited by applicant]
WO 2017156392A1 · 2017 [cited by applicant]